| Year |
Citation |
Score |
| 2019 |
Sokolowski K, Buhrman JS, Gemeinhart RA. PCL19-114: Development of Locally Deliverable Polymeric Microspheres With Environmentally Specific Release for the Improvement of Cancer Therapy Journal of the National Comprehensive Cancer Network. 17: PCL19-114. DOI: 10.6004/Jnccn.2018.7223 |
0.714 |
|
| 2016 |
Zhang Y, Buhrman JS, Liu Y, Rayahin JE, Gemeinhart RA. Reducible Micelleplexes are Stable Systems for Anti-miRNA Delivery in Cerebrospinal Fluid. Molecular Pharmaceutics. 13: 1791-9. PMID 27177352 DOI: 10.1021/Acs.Molpharmaceut.5B00933 |
0.738 |
|
| 2016 |
Jaishankar D, Buhrman JS, Valyi-Nagy T, Gemeinhart RA, Shukla D. Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection. Investigative Ophthalmology & Visual Science. 57: 169-80. PMID 26780322 DOI: 10.1167/Iovs.15-18365 |
0.653 |
|
| 2015 |
Rayahin JE, Buhrman JS, Zhang Y, Koh TJ, Gemeinhart RA. High and low molecular weight hyaluronic acid differentially influence macrophage activation. Acs Biomaterials Science & Engineering. 1: 481-493. PMID 26280020 DOI: 10.1021/Acsbiomaterials.5B00181 |
0.711 |
|
| 2014 |
Rayahin JE, Buhrman JS, Gemeinhart RA. Melittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 65: 112-21. PMID 25240321 DOI: 10.1016/J.Ejps.2014.09.012 |
0.758 |
|
| 2014 |
Zhang Y, Köllmer M, Buhrman JS, Tang MY, Gemeinhart RA. Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential. Peptides. 58: 83-90. PMID 24969623 DOI: 10.1016/J.Peptides.2014.06.008 |
0.708 |
|
| 2013 |
Köllmer M, Buhrman JS, Zhang Y, Gemeinhart RA. Markers Are Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells. Journal of Developmental Biology and Tissue Engineering. 5: 18-25. PMID 24013643 DOI: 10.5897/JDBTE2013.0065 |
0.709 |
|
| 2013 |
Buhrman JS, Rayahin JE, Cook LC, Federle MJ, Gemeinhart RA. Active, soluble recombinant melittin purified by extracting insoluble lysate of Escherichia coli without denaturation. Biotechnology Progress. 29: 1150-7. PMID 23926061 DOI: 10.1002/Btpr.1784 |
0.743 |
|
| 2013 |
Buhrman JS, Cook LC, Rayahin JE, Federle MJ, Gemeinhart RA. Proteolytically activated anti-bacterial hydrogel microspheres. Journal of Controlled Release : Official Journal of the Controlled Release Society. 171: 288-95. PMID 23816641 DOI: 10.1016/J.Jconrel.2013.06.023 |
0.761 |
|
| 2012 |
Buhrman JS, Rayahin JE, Köllmer M, Gemeinhart RA. In-house preparation of hydrogels for batch affinity purification of glutathione S-transferase tagged recombinant proteins. Bmc Biotechnology. 12: 63. PMID 22989306 DOI: 10.1186/1472-6750-12-63 |
0.691 |
|
| 2012 |
Rayahin JE, Buhrman JS, Gemeinhart RA. Hybrid nanocrystals: University of Kentucky US20060280680A1. Expert Opinion On Therapeutic Patents. 22: 341-8. PMID 22364361 DOI: 10.1517/13543776.2012.665877 |
0.718 |
|
| 2011 |
Kleijn A, Chen JW, Buhrman JS, Wojtkiewicz GR, Iwamoto Y, Lamfers ML, Stemmer-Rachamimov AO, Rabkin SD, Weissleder R, Martuza RL, Fulci G. Distinguishing inflammation from tumor and peritumoral edema by myeloperoxidase magnetic resonance imaging. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4484-93. PMID 21558403 DOI: 10.1158/1078-0432.Ccr-11-0575 |
0.301 |
|
| 2009 |
Passer BJ, Castelo-Branco P, Buhrman JS, Varghese S, Rabkin SD, Martuza RL. Oncolytic herpes simplex virus vectors and taxanes synergize to promote killing of prostate cancer cells. Cancer Gene Therapy. 16: 551-60. PMID 19197321 DOI: 10.1038/Cgt.2009.10 |
0.309 |
|
| Show low-probability matches. |